IRVINE, Calif., Sept. 23, 2026 /PRNewswire/ — OrthAlign, Inc., the global leader in handheld orthopedic enabling technology, today announced that its technology has been used in more than 500,000 joint replacement procedures worldwide, a milestone that reflects strong surgeon adoption and emphasizes the company’s sustainable impact on orthopedics.
OrthAlign Surpasses 500,000 Joint Replacement Procedures Worldwide
2 min read Premium comments
OrthAligntotal kneejoint replacement procedurestotal hippartial kneeligament balancing
This milestone represents the collective experience of thousands of surgeons across more than twenty countries, spanning total hip, total knee, partial knee and ligament balancing in primary and revision knee procedures. From hospitals and academic medical centers to ambulatory surgery centers, OrthAlign technology is used across a broad range of care settings, surgical approaches and implant systems, reflecting the reach and versatility of OrthAlign’s technology portfolio. Surgeons continue to choose OrthAlign independent of their implant system, validating the value and staying power of an accurate, efficient and cost-effective technology.
“Reaching 500,000 procedures is an important milestone for OrthAlign and underscores the growing need for economically and operationally efficient technology solutions,” said Eric Timko, Chairman and CEO of OrthAlign. “None of this happens without the surgeons who trust our technology every day, our distribution partners around the world and our employees, who have built OrthAlign. We thank them for getting us here, and are excited about where we are going.”
OrthAlign’s continued growth is driven by three significant opportunities: the migration of joint replacement to ambulatory surgery centers (ASCs), expansion into global markets, and broader adoption of its open-platform technology across hip and knee arthroplasty, areas where OrthAlign excels and fulfills its mission of making empowering technologies accessible to all.
“We’re just getting started,” added Timko. “We’ll keep innovating, executing and building the right partnerships to bring OrthAlign to more surgeons and patients. The opportunity ahead of us has never been greater. Our focus now is on how quickly we can reach one million procedures.”
About OrthAlign, Inc.
OrthAlign is a medical device company with a focus on delivering practical, cutting-edge technologies for orthopedic surgery. With a commitment to innovation and excellence, OrthAlign provides surgeons with user-friendly, cost-effective solutions to improve patient care in joint replacement.
Driven by the belief that everyone deserves exceptional healthcare, we are committed to making empowering technologies accessible to all.
For more information regarding OrthAlign, please visit www.orthalign.com.
Lantern is a registered trademark of OrthAlign, Inc.
SOURCE OrthAlign
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
OrthAlign has surpassed 500,000 joint replacement procedures globally, driven by strong surgeon adoption, ASC migration, and international expansion. This milestone validates their open-platform, cost-effective technology, which is chosen independently of implant systems across diverse care settings. The company's strategy focuses on efficiency and accessibility, aiming for one million procedures through continued innovation and strategic partnerships, reinforcing its market leadership in handheld orthopedic enabling technology.
- The company's growth strategy leverages the shift to ambulatory surgery centers and global market penetration.
- OrthAlign's open-platform technology offers economic and operational efficiency, appealing to surgeons across various implant systems.
PhD Lens: Clinical and outcomes impact
OrthAlign's handheld orthopedic enabling technology has been utilized in over 500,000 joint replacement procedures worldwide, encompassing total hip, total knee, partial knee, and ligament balancing in primary and revision knee surgeries. This widespread adoption across various surgical approaches and implant systems suggests the technology's versatility and perceived accuracy. The company emphasizes its role in providing user-friendly, efficient, and accessible solutions for improving patient care.
- The technology provides accurate and efficient guidance for a broad spectrum of joint replacement procedures.
- Its open-platform nature allows integration with diverse implant systems, reflecting its adaptability in clinical settings.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.